New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb's Stellaris PC: Company debuts its Stellaris PC (Procedural Choice) vision enhancement system overseas following CE mark approval last May. The combined vitrectomy and phacoemulsification system, for which a May 510(k) submission remains pending at FDA, enhances surgeons' ability to see ocular tissue under various surgical conditions, B&L claims. Stellaris PC is indicated for emulsification and removal of cataracts, and anterior and posterior segment vitrectomy
You may also be interested in...
Perseon Cancer Ablation Therapy Expanded To Treat Liver Tumors
The newly renamed company says FDA has cleared its MicroThermX microwave ablation system to treat complicated non-resectable liver tumors.
Financings In Brief
EnteroMedics plans secondary offering
Financings In Brief
EnteroMedics plans secondary offering